Applications from the field of Clinical Research from Agilent Technologies | LabRulez ICPMS

Targeted Phosphoproteomics Analysis of Immunoaffinity Enriched Tyrosine Phosphorylation in Mouse Tissue

Applications

| 2014 | Agilent Technologies

Sample Preparation, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

Sample Preparation, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Clinical Research

Benefits of the Cary 3500 Multicell UV-Vis for Protein Analysis

Applications

| 2018 | Agilent Technologies

UV–VIS spectrophotometry

Instrumentation

UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Clinical Research

Tools to Understand the Gut Microbiome: A Refined LC-MS/MS Method to Profile Bacteria-derived Bile Acids

Posters

| 2017 | Agilent Technologies (ASMS)

LC/MS, LC/MS/MS, LC/QQQ

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ

Manufacturer

Agilent Technologies

Industries

Clinical Research

Agilent SLIMS for Biobanks

Brochures and specifications

| 2021 | Agilent Technologies

Software

Instrumentation

Software

Manufacturer

Agilent Technologies

Industries

Clinical Research

Quantitative determination of cisplatin in plasma and urine in clinical research by triple quadrupole LC/MS/MS

Applications

| 2018 | Agilent Technologies

LC/MS, LC/MS/MS, LC/QQQ

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ

Manufacturer

Agilent Technologies

Industries

Clinical Research

Long-Term Robustness of Agilent LC/Q-TOF Systems for Untargeted Lipidomics

Applications

| 2023 | Agilent Technologies

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Clinical Research, Lipidomics

An LC/MS Metabolomics Discovery Workflow for Malaria-Infected Red Blood Cells Using Mass Profiler Professional Software and LC-Triple Quadrupole MRM Confirmation

Applications

| 2015 | Agilent Technologies

Software, LC/MS, LC/MS/MS, LC/QQQ

Instrumentation

Software, LC/MS, LC/MS/MS, LC/QQQ

Manufacturer

Agilent Technologies

Industries

Metabolomics, Clinical Research

A Refined LC-MS/MS Method Targeting Bile Acids from the Gut Microbiome

Posters

| 2018 | Agilent Technologies (ASMS)

LC/MS, LC/MS/MS, LC/QQQ

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ

Manufacturer

Agilent Technologies

Industries

Clinical Research

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

Applications

| 2018 | Agilent Technologies

LC/MS, LC/MS/MS, LC/QQQ

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ

Manufacturer

Agilent Technologies

Industries

Clinical Research

Determination of Drug-to-Antibody Ratio for Antibody-Drug Conjugates Purified from Serum

Applications

| 2016 | Agilent Technologies

Sample Preparation, Software, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

Sample Preparation, Software, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Clinical Research

Applications from the field of Clinical Research from Agilent Technologies | LabRulez ICPMS

Targeted Phosphoproteomics Analysis of Immunoaffinity Enriched Tyrosine Phosphorylation in Mouse Tissue

Benefits of the Cary 3500 Multicell UV-Vis for Protein Analysis

Tools to Understand the Gut Microbiome: A Refined LC-MS/MS Method to Profile Bacteria-derived Bile Acids

Agilent SLIMS for Biobanks

Quantitative determination of cisplatin in plasma and urine in clinical research by triple quadrupole LC/MS/MS

Long-Term Robustness of Agilent LC/Q-TOF Systems for Untargeted Lipidomics

An LC/MS Metabolomics Discovery Workflow for Malaria-Infected Red Blood Cells Using Mass Profiler Professional Software and LC-Triple Quadrupole MRM Confirmation

A Refined LC-MS/MS Method Targeting Bile Acids from the Gut Microbiome

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

Determination of Drug-to-Antibody Ratio for Antibody-Drug Conjugates Purified from Serum

Related content

Environmental chemist Branislav Vrana: To the first conference, we drove in an old Skoda Felicia

The world around us is changing and we have to react

"The first science communicators for me were already high school teachers,” says researcher and laureate of the Learned Society of the Czech Republic award, Barbora Rudzanová.